December 17, 2009 - Partial breast irradiation "is an approach that may allow more patients to undergo breast-conserving therapy more quickly, at lower cost, and with less risk of long-term complications,” said The American College of Surgeons (ACS) in a consensus statement.*

In the document, the ACS emphasized the advantages of accelerated partial breast irradiation by delivering brachytherapy with open single-entry devices with multiple lumens. This technique includes SAVI radiation therapy provided at the Breast Clinic of Memphis. SAVI provides APBI, a shortened course of high-dose radiation therapy for early-stage breast cancer patients following lumpectomy surgery. The treatment is completed in just five days — compared to the six weeks of treatment, five days a week, required for traditional, external-beam radiation.

The device's multi-catheter design allows physicians to target radiation to the area that needs it most, minimizing exposure to healthy tissue. Precisely sculpted radiation is delivered from within the breast and targets the area where the cancer is most likely to recur.

In related news, Cianna Medical announced it has received ISO 13485:2003 certification for its quality management system for the design, development and manufacture of the SAVI breast brachytherapy applicator, which delivers targeted radiation therapy for the treatment of early-stage breast cancer.

The certification allows Cianna Medical to continue with the CE Mark registration process, which is required for sales within the European Economic Community. The CE Mark will apply to all four sizes of SAVI and the SAVI Prep Catheter.

The device's multi-catheter design enables physicians to direct radiation where it is needed most, while minimizing exposure to healthy structures, like the skin, chest wall or lungs. The ability to customize radiation based on patient-specific anatomy is said to help reduce complications typically associated with radiation therapy and allows physicians to offer the five-day treatment to more women.

The SAVI applicator received its 510(K) clearance from the U.S. Food & Drug Administration in July 2006.

*The ACS statement, titled “Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment,” was published in the October 2009 issue of the Journal of the American College of Surgeons.

For more information: www.facs.org and www.ciannamedical.com

Related Content

360 Photos | Brachytherapy Systems

This is a 360 degree view inside one of the brachytherapy treatment rooms at Northwestern Medicine's center in ...

Time October 28, 2021
arrow
News | Brachytherapy Systems

August 31, 2021 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

Time August 31, 2021
arrow
News | Radiation Oncology

June 2, 2021 — A breast cancer therapy that requires just one shot of radiotherapy is as effective as traditional ...

Time June 02, 2021
arrow
News | Brachytherapy Systems, Women's Healthcare

May 19, 2021 — A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells ...

Time May 19, 2021
arrow
News | Brachytherapy Systems

October 26, 2020 — iCAD, Inc. announced the Company will showcase the expanded platform for the Xoft Axxent Electronic ...

Time October 26, 2020
arrow
News | Brachytherapy Systems, Women's Healthcare

September 8, 2020 — Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the ...

Time September 08, 2020
arrow
News | Brachytherapy Systems, Women's Healthcare

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation Therapy, makers of AccuBoost, announced the latest upgrades to the AccuBoost Digital platform. AccuBoost Digital leverages the Planmed Clarity digital mammography system to provide doctors with real-time image-guidance and targeting confidence in the delivery of accelerated partial breast irradiation (APBI) in patients opting for breast conserving therapy (BCT). These upgrades improve the treatment workflow, patient experience and user interface. By design, this non-invasive breast brachytherapy (NIBB) technique is 100 percent adaptive as each treatment fraction is assessed independently and is ideal for the challenges that APBI treatments can present.

Time October 23, 2019
arrow
Videos | Radiation Therapy

ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at the ...

Time February 21, 2019
arrow
News | Brachytherapy Systems, Women's Healthcare

Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent Electronic Brachytherapy (eBx) System were comparable to those seen in the TARGIT-A and ELIOT trials, according to new results. The results, published in the Annals of Surgical Oncology, came from a long-term study conducted at Hoag Memorial Hospital Presbyterian in Newport Beach, Calif.

Time January 07, 2019
arrow
News | Women's Health

Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to acquire Cianna Medical Inc., headquartered in Aliso Viejo, Calif. The deal structure includes an upfront payment of $135 million with potential earn-out payments of an additional $15 million for achievement of supply chain and scalability metrics, and up to an additional $50 million for achievement of sales milestones.

Time November 14, 2018
arrow
Subscribe Now